comparemela.com

Page 2 - Richard Eisenstadt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Altimmune to Participate at Two Upcoming Investor Conferences

GAITHERSBURG, Md., May 31, 2023 Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be. | May 31, 2023

Altimmune to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on February 28, 2023

21.02.2023 - GAITHERSBURG, Md., Feb. 21, 2023 (GLOBE NEWSWIRE) - Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, February 28, .

Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022

GAITHERSBURG, Md., June 17, 2022 Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Medical Director, Pinnacle Clinical Research, will. | June 17, 2022

Altimmune to Present at Upcoming Investor Conferences

GAITHERSBURG, Md., May 16, 2022 Altimmune, Inc. , a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the. | May 16, 2022

Altimmune to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

Altimmune to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.